Cargando…
The Sirt1/P53 Axis in Diabetic Intervertebral Disc Degeneration Pathogenesis and Therapeutics
Intervertebral disc degeneration (IDD) is one of the major causes of low back pain. Diabetes is a risk factor for IDD and may aggravate IDD in rats; however, the mechanism is poorly understood. Previously, we demonstrated that apoptosis and senescence were increased in diabetic nucleus pulposus (NP)...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754956/ https://www.ncbi.nlm.nih.gov/pubmed/31583043 http://dx.doi.org/10.1155/2019/7959573 |
_version_ | 1783453148600336384 |
---|---|
author | Zhang, Zengjie Lin, Jialiang Nisar, Majid Chen, Tingting Xu, Tianzhen Zheng, Gang Wang, Chenggui Jin, Haiming Chen, Jiaoxiang Gao, Weiyang Tian, Naifeng Wang, Xiangyang Zhang, Xiaolei |
author_facet | Zhang, Zengjie Lin, Jialiang Nisar, Majid Chen, Tingting Xu, Tianzhen Zheng, Gang Wang, Chenggui Jin, Haiming Chen, Jiaoxiang Gao, Weiyang Tian, Naifeng Wang, Xiangyang Zhang, Xiaolei |
author_sort | Zhang, Zengjie |
collection | PubMed |
description | Intervertebral disc degeneration (IDD) is one of the major causes of low back pain. Diabetes is a risk factor for IDD and may aggravate IDD in rats; however, the mechanism is poorly understood. Previously, we demonstrated that apoptosis and senescence were increased in diabetic nucleus pulposus (NP) tissues; in the current study, we found that hyperglycaemia may promote the incidence of apoptosis and senescence in NP cells in vitro. Meanwhile, the acetylation of P53, a master transcription factor of apoptosis and senescence, was also found increased in diabetic NP tissues in vivo as well as in hyperglycaemic NP cells in vitro. Sirt1 is an NAD(+)-dependent deacetylase, and we showed that the expression of Sirt1 was decreased in NP tissues, while hyperglycaemia could suppress the expression and activity of Sirt1 in NP cells. Furthermore, we demonstrated that butein may inhibit acetylation of P53 and protect NP cells against hyperglycaemia-induced apoptosis and senescence through Sirt1 activation, as the Sirt1 inhibitor Ex527 may counteract the protective effect of butein in hyperglycaemic NP cells. An in vivo study showed that butein could ameliorate the IDD process in diabetic rats, while Sirt1 was increased and acetyl-p53 was decreased in NP tissues in butein-treated rats. These results indicate that the Sirt1/P53 axis is involved in the pathogenesis of diabetic IDD and may serve as a therapeutic target for diabetic IDD. |
format | Online Article Text |
id | pubmed-6754956 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-67549562019-10-03 The Sirt1/P53 Axis in Diabetic Intervertebral Disc Degeneration Pathogenesis and Therapeutics Zhang, Zengjie Lin, Jialiang Nisar, Majid Chen, Tingting Xu, Tianzhen Zheng, Gang Wang, Chenggui Jin, Haiming Chen, Jiaoxiang Gao, Weiyang Tian, Naifeng Wang, Xiangyang Zhang, Xiaolei Oxid Med Cell Longev Research Article Intervertebral disc degeneration (IDD) is one of the major causes of low back pain. Diabetes is a risk factor for IDD and may aggravate IDD in rats; however, the mechanism is poorly understood. Previously, we demonstrated that apoptosis and senescence were increased in diabetic nucleus pulposus (NP) tissues; in the current study, we found that hyperglycaemia may promote the incidence of apoptosis and senescence in NP cells in vitro. Meanwhile, the acetylation of P53, a master transcription factor of apoptosis and senescence, was also found increased in diabetic NP tissues in vivo as well as in hyperglycaemic NP cells in vitro. Sirt1 is an NAD(+)-dependent deacetylase, and we showed that the expression of Sirt1 was decreased in NP tissues, while hyperglycaemia could suppress the expression and activity of Sirt1 in NP cells. Furthermore, we demonstrated that butein may inhibit acetylation of P53 and protect NP cells against hyperglycaemia-induced apoptosis and senescence through Sirt1 activation, as the Sirt1 inhibitor Ex527 may counteract the protective effect of butein in hyperglycaemic NP cells. An in vivo study showed that butein could ameliorate the IDD process in diabetic rats, while Sirt1 was increased and acetyl-p53 was decreased in NP tissues in butein-treated rats. These results indicate that the Sirt1/P53 axis is involved in the pathogenesis of diabetic IDD and may serve as a therapeutic target for diabetic IDD. Hindawi 2019-09-09 /pmc/articles/PMC6754956/ /pubmed/31583043 http://dx.doi.org/10.1155/2019/7959573 Text en Copyright © 2019 Zengjie Zhang et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Zhang, Zengjie Lin, Jialiang Nisar, Majid Chen, Tingting Xu, Tianzhen Zheng, Gang Wang, Chenggui Jin, Haiming Chen, Jiaoxiang Gao, Weiyang Tian, Naifeng Wang, Xiangyang Zhang, Xiaolei The Sirt1/P53 Axis in Diabetic Intervertebral Disc Degeneration Pathogenesis and Therapeutics |
title | The Sirt1/P53 Axis in Diabetic Intervertebral Disc Degeneration Pathogenesis and Therapeutics |
title_full | The Sirt1/P53 Axis in Diabetic Intervertebral Disc Degeneration Pathogenesis and Therapeutics |
title_fullStr | The Sirt1/P53 Axis in Diabetic Intervertebral Disc Degeneration Pathogenesis and Therapeutics |
title_full_unstemmed | The Sirt1/P53 Axis in Diabetic Intervertebral Disc Degeneration Pathogenesis and Therapeutics |
title_short | The Sirt1/P53 Axis in Diabetic Intervertebral Disc Degeneration Pathogenesis and Therapeutics |
title_sort | sirt1/p53 axis in diabetic intervertebral disc degeneration pathogenesis and therapeutics |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754956/ https://www.ncbi.nlm.nih.gov/pubmed/31583043 http://dx.doi.org/10.1155/2019/7959573 |
work_keys_str_mv | AT zhangzengjie thesirt1p53axisindiabeticintervertebraldiscdegenerationpathogenesisandtherapeutics AT linjialiang thesirt1p53axisindiabeticintervertebraldiscdegenerationpathogenesisandtherapeutics AT nisarmajid thesirt1p53axisindiabeticintervertebraldiscdegenerationpathogenesisandtherapeutics AT chentingting thesirt1p53axisindiabeticintervertebraldiscdegenerationpathogenesisandtherapeutics AT xutianzhen thesirt1p53axisindiabeticintervertebraldiscdegenerationpathogenesisandtherapeutics AT zhenggang thesirt1p53axisindiabeticintervertebraldiscdegenerationpathogenesisandtherapeutics AT wangchenggui thesirt1p53axisindiabeticintervertebraldiscdegenerationpathogenesisandtherapeutics AT jinhaiming thesirt1p53axisindiabeticintervertebraldiscdegenerationpathogenesisandtherapeutics AT chenjiaoxiang thesirt1p53axisindiabeticintervertebraldiscdegenerationpathogenesisandtherapeutics AT gaoweiyang thesirt1p53axisindiabeticintervertebraldiscdegenerationpathogenesisandtherapeutics AT tiannaifeng thesirt1p53axisindiabeticintervertebraldiscdegenerationpathogenesisandtherapeutics AT wangxiangyang thesirt1p53axisindiabeticintervertebraldiscdegenerationpathogenesisandtherapeutics AT zhangxiaolei thesirt1p53axisindiabeticintervertebraldiscdegenerationpathogenesisandtherapeutics AT zhangzengjie sirt1p53axisindiabeticintervertebraldiscdegenerationpathogenesisandtherapeutics AT linjialiang sirt1p53axisindiabeticintervertebraldiscdegenerationpathogenesisandtherapeutics AT nisarmajid sirt1p53axisindiabeticintervertebraldiscdegenerationpathogenesisandtherapeutics AT chentingting sirt1p53axisindiabeticintervertebraldiscdegenerationpathogenesisandtherapeutics AT xutianzhen sirt1p53axisindiabeticintervertebraldiscdegenerationpathogenesisandtherapeutics AT zhenggang sirt1p53axisindiabeticintervertebraldiscdegenerationpathogenesisandtherapeutics AT wangchenggui sirt1p53axisindiabeticintervertebraldiscdegenerationpathogenesisandtherapeutics AT jinhaiming sirt1p53axisindiabeticintervertebraldiscdegenerationpathogenesisandtherapeutics AT chenjiaoxiang sirt1p53axisindiabeticintervertebraldiscdegenerationpathogenesisandtherapeutics AT gaoweiyang sirt1p53axisindiabeticintervertebraldiscdegenerationpathogenesisandtherapeutics AT tiannaifeng sirt1p53axisindiabeticintervertebraldiscdegenerationpathogenesisandtherapeutics AT wangxiangyang sirt1p53axisindiabeticintervertebraldiscdegenerationpathogenesisandtherapeutics AT zhangxiaolei sirt1p53axisindiabeticintervertebraldiscdegenerationpathogenesisandtherapeutics |